PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: A Nuclear Receptor Signaling Pathway in Lipid Physiology
Thomas Lemberger, Béatrice Desvergne, Walter Wahli · Annual Review of Cell and Developmental Biology · 1996
Peroxisome proliferator-activated receptors (PPARs) are lipid-activated transcription factors that belong to the steroid/thyroid/retinoic acid receptor superfamily. All their characterized target genes encode proteins that participate in lipid homeostasis. The recent finding that antidiabetic thiazolidinediones and adipogenic prostanoids are ligands of one of the PPARs reveals a novel signaling pathway that directly links these compounds to processes involved in glucose homeostasis and lipid metabolism including adipocyte differentiation. A detailed understanding of this pathway could designate PPARs as targets for the development of novel efficient treatments for several metabolic disorders.
Cited by 712 works. doi:10.1146/annurev.cellbio.12.1.335
Authors
References
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
- A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
- Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors
- The RXR heterodimers and orphan receptors
- Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
- Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors